[Federal Register Volume 67, Number 210 (Wednesday, October 30, 2002)]
[Notices]
[Pages 66162-66163]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-27574]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Vaccines and Related Biological Products Advisory Committee; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Vaccines and Related Biological Products 
Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on November 18, 2002, from 
1 p.m. to 3:30 p.m.
    Location: Food and Drug Administration, Bldg 29B, conference room 
C, 29 Lincoln Dr., Bethesda, MD.

[[Page 66163]]

This meeting will be held by a telephone conference call. The public is 
welcome to attend the open portion of the meeting. A speaker phone will 
be provided at the specified location.
    Contact Person: Jody G. Sachs or Denise H. Royster, Center for 
Biologics Evaluation and Research (HFM-71), Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301 827-0314, 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12391. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: The committee will review and discuss the intramural 
research programs of the Laboratory of Enteric and Sexually Transmitted 
Diseases, Office of Vaccines Research and Review.
    Procedure: On November 18, 2002, from 1 p.m. to 3 p.m., the meeting 
is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the committee. Written submissions may be made to the contact person by 
November 1, 2002. Oral presentations from the public will be scheduled 
between approximately 2 p.m. and 3 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before November 1, 2002, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Closed Committee Deliberations: On November 18, 2002, from 3 p.m. 
to 3:30 p.m., the meeting will be closed to permit discussion where 
disclosure would constitute a clearly unwarranted invasion of personal 
privacy (5 U.S.C. 552b(c)(6)).
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Jody G. Sachs or 
Denise H. Royster at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: October 23, 2002.
LaJuana D. Caldwell,
Acting Senior Associate Commissioner for External Relations.
[FR Doc. 02-27574 Filed 10-29-02; 8:45 am]
BILLING CODE 4160-01-S